 - Determine the safety of adjuvant transdermal vaccine therapy comprising multi-epitope melanoma peptides MP, tetanus toxoid helper peptide TET, and sargramostim GM-CSF in combination with Montanide ISA-51 or dimethyl sulfoxide with or without imiquimod in patients who have undergone surgical resection for stage II-IV melanoma. 